GIP hFc Chimera, Human

GIP hFc Chimera, Human
Item number Size Datasheet Manual SDS Delivery time Quantity Price
GSC-Z05353-100 100 µg -

Request delivery time estimate

457.00€
GSC-Z05353-500 500 µg -

Request delivery time estimate

1,505.00€
 
The potential application of glucose-dependent insulinotropic polypeptide (gastric inhibitory... more
Product information "GIP hFc Chimera, Human"
The potential application of glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide, GIP) in the management of obesity and type 2 diabetes has been controversial. Initial interest in the therapeutic use of GIP was dampened by evidence that its insulinotropic activity was reduced in type 2 diabetes and by reports that it increased glucagon secretion and adipose deposition in non-diabetic individuals.
Keywords: GIP, Incretin hormone, Gastric inhibitory polypeptide, Glucose-dependent insulinotropic polypeptide
Supplier: GenScript
Supplier-Nr: Z05353

Properties

Conjugate: No
Species reactivity: human
MW: 34.9 kD
Purity: >95% (Bis-Tris PAGE)

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: °C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "GIP hFc Chimera, Human"
Write a review
or to review a product.
Viewed